1 Boring Old Man theorizes (with a nod to Bob Fiddaman) that the recent appearance of data from study 329 and Glaxo’s pledge to publish data from clinical trials is part of a quiet deal with the Department of Justice to save face.
1 Boring Old Man theorizes (with a nod to Bob Fiddaman) that the recent appearance of data from study 329 and Glaxo’s pledge to publish data from clinical trials is part of a quiet deal with the Department of Justice to save face.
